UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 20, 2015
| BIOANALYTICAL SYSTEMS, INC. |
| (Exact name of registrant as specified in its charter) |
| Indiana | | 0-23357 | | 35-1345024 |
(State or other jurisdiction of
incorporation or organization) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
2701 KENT AVENUE WEST LAFAYETTE, INDIANA | | 47906-1382 |
| (Address of principal executive offices) | | (Zip Code) |
Registrant's telephone number, including area code: (765) 463-4527
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act(17CFR240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act(17CFR240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act(17CFR240.13e-4(c)) |
| Item 7.01 | Regulation FD Disclosure |
Bioanalytical Systems, Inc. (“BASi”) previously announced that the Company will be presenting at the Tenth Annual Noble Financial Capital Markets Equity Conference on Tuesday, January 20, 2015 at 11:00 a.m. EST in Room 1 at the Club Med in Sandpiper Bay, Florida. The audio high-definition video of BASi's presentation will be webcast live on theInvestors tab atwww.BASinc.comor atwww.Noblefcm.com.The webcast requires the installation of Microsoft Silverlight viewer and will be available for replay at BASi's website for 90 days after the presentation. Copies of the presentation materials are also available online from theInvestors tab atwww.BASinc.comand are attached as Exhibit 99.1 to this Current Report and are incorporated herein by reference. The Company may also use these slides at future conferences.
| Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
| 99.1 | Slide Presentation for Tenth Annual Noble Financial Capital Markets Equity Conference to be held on January 20, 2015. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | Bioanalytical Systems, Inc. | |
| | | | |
| | | | |
| | | | |
| Date: January 20, 2015 | By: | /s/Jeff Potrzebowski | |
| | | Jeff Potrzebowski | |
| | | Chief Financial Officer and Vice President of Finance | |
